Weekly shot tested to curb drinking and shed pounds
NCT ID NCT07292519
Summary
This study is testing if a weekly injection called Tirzepatide, combined with a computer-based therapy program, can help adults who struggle with heavy drinking and are also overweight or obese. The main goal is to see if this approach reduces the number of days people drink heavily over an 8-week period. Researchers will also check if it helps with weight loss and improves markers of heart health and diabetes risk.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COMORBIDITIES AND COEXISTING CONDITIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Drug Health Services, Royal Prince Alfred Hospital
Sydney, New South Wales, 2050, Australia
Contact Phone: •••-•••-••••
Contact Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.